Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Is Expected to Reach USD 7.9 Billion by 2018
CTCs and CSCs Market is estimated to reach USD 7.9 billion by 2018. The study shows that in the overall CTCs and CSCs global market, the U.S. is expected to maintain its lead position in terms of revenue till 2018. The global market for cancer diagnostics based on Circulating Cancer Cells (CTCs) was estimated at USD 1.0 billionin 2011.
View full press release